Name: Revenue of the analgesics market worldwide by country 2018
Creator: Statista

Health & Pharmaceuticals

This statistic depicts the revenue of the analgesics market in 2018, by country. In that year, the analgesics market revenue in the U.S. amounted to approximately 5,287.28 million U.S. dollars. For information on over 200 markets in 150 countries, please visit Consumer Market Outlook.

Revenue of the analgesics market worldwide by country in 2018 (in million U.S. dollars)

Source

Show detailed source information?

Already a member?

Source

Show sources information

Show publisher information

More information

Supplementary notes

The analgesics segment comprises over-the-counter natural and synthetic non-opioid analgesics (only in approved low doses) like Paracetamol, Ibuprofen, Aspirin, Diclofenac and other pain-relieving preparations. Legislation on opioid analgesics differs from country to country. According to the respective state legislation, legal opioid analgesics are included. In Germany, Austria and Switzerland, for instance, opioid analgesics are only included if they are not limited by the narcotics law and do not require prescription. Analgesics are included in the form of pills, capsules, gels and ointments. Not included are prescription medicines (e.g. morphine), anesthetics and homeopathic remedies. Among the top-selling painkillers are Voltaren, Aspirin, Thomapyrin, Ibuprofen, Dolormin, Paracetamol and ASS. It includes both products which are exclusively sold in pharmacies and products which can be purchased elsewhere. Sales by hospitals are not included.